Devdaru

<h3> Absolute Contraindications of Devdaru </h3> <h4>Pregnancy and Breastfeeding [Avoid ingestion or strong inhalation during pregnancy or nursing]</h4> <ul> <li>🤰</li> <li>Recommendation: Do not ingest essential oils or concentrated Devdaru (Cedrus deodara) preparations during pregnancy or while breastfeeding; avoid high-dose inhalation. Seek medical advice before any use.</li> <li>Reasoning: Certain essential-oil constituents (including anethole and other bioactive volatiles that occur in C. deodara) have been associated with reproductive toxicity, hormonal modulation, or fetal effects in experimental studies; therefore concentrated oils are considered potentially unsafe in pregnancy. </li> <li>Scientific_Study_Title: Maternal Reproductive Toxicity of Some Essential Oils and Their Constituents</li> <li>Scientific_Study_Authors: Noura S Dosoky, William N Setzer</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/33673548/</li> <li>Scientific_Study_Excerpt: <p>This review summarizes experimental evidence that some essential-oil constituents (for example anethole, camphor, thujone, pulegone and others) can cause adverse effects on female reproduction, including abortion, hormonal modulation, maternal toxicity, teratogenicity and embryo-fetotoxicity in animal studies. The authors caution that, although many plants may have beneficial effects, use of herbal preparations and concentrated essential oils during pregnancy remains questionable because these constituents can affect reproductive endpoints in preclinical models. The paper highlights the need for caution and further safety evaluation before recommending essential oils in pregnancy.</p> </li> </ul> <h4>Active Peptic Ulcer or Severe Gastrointestinal Mucosal Disease [If you have peptic ulcer disease or inflamed gut]</h4> <ul> <li>🩺</li> <li>Recommendation: Avoid oral use of concentrated Devdaru root oil or undiluted extracts if you have active ulcers, gastritis, or recent GI bleeding. Consult your doctor before use.</li> <li>Reasoning: Animal studies of Cedrus deodara root oil showed erosion, mucosal edema, congestion and inflammatory cell infiltration in esophagus, stomach and ileum after dosing; such mucosal irritation could worsen active ulceration.</li> <li>Scientific_Study_Title: Assessment of Cedrus deodara root oil on the histopathological changes in the gastrointestinal tissues in rats</li> <li>Scientific_Study_Authors: Rehana Perveen, Mohammad Ahmed Azmi, Ijaz Hussain Zaidi, Syed Naeemul-Hassan Naqvi, Syed Mohammad Mahmood, Kiran Ajmal, Mohammad Usman</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/23625432/</li> <li>Scientific_Study_Excerpt: <p>In a rat study, animals given Cedrus deodara root oil (0.5 and 2.5 ml/kg single doses) exhibited epithelial erosion, submucosal and mucosal edema, vascular congestion and inflammatory cell infiltration in esophagus, stomach and ileum; shortening of villi was also reported. Authors concluded that while the oil was not lethal at tested doses, it produced adverse histologic changes in gastrointestinal tissues and recommended further safety evaluation before therapeutic use.</p> </li> </ul> <h4>Known Fragrance / Essential-Oil Allergy or Contact Dermatitis [If you have previous allergy to cedar or fragrance mixes]</h4> <ul> <li>🚫</li> <li>Recommendation: Do not use Devdaru topical oils, perfumes, or fragranced products if you have known fragrance allergies or prior reactions to cedarwood; perform patch testing under clinician guidance if exposure is required.</li> <li>Reasoning: Fragrance mixes and some tree/wood oils (including cedarwood) are established causes of allergic contact dermatitis; exposure to cedarwood oils can provoke skin reactions in sensitized individuals.</li> <li>Scientific_Study_Title: Contact allergy caused by fragrance mix and Myroxylon pereirae (balsam of Peru)--a retrospective study</li> <li>Scientific_Study_Authors: Petra Turić, Jasna Lipozencić, Visnja Milavec-Puretić, Sandra Marinović Kulisić</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/21661358/</li> <li>Scientific_Study_Excerpt: <p>In a retrospective patch-test study of patients with contact dermatitis, fragrances were a common cause of allergic reactions. The analysis lists several fragrance components and botanical oils (including cedarwood) as potential sensitizers. The work underscores that fragrance materials - tree moss, ylang ylang, lemongrass, sandalwood and cedarwood among them - can cause positive patch test reactions and that patients with suspected fragrance allergy require careful testing and avoidance strategies.</p> </li> </ul> <h4>Concomitant use with drugs highly dependent on CYP3A4 / CYP2B6 (e.g., certain anticonvulsants, some chemotherapeutics, select antiretrovirals) [Risk of clinically relevant drug interactions]</h4> <ul> <li>⚠️</li> <li>Recommendation: Avoid concurrent use of concentrated Devdaru essential oil or high-dose extracts with medications that are mainly cleared by CYP3A4 or CYP2B6 unless supervised by a physician; do not self-mix with prescription drugs.</li> <li>Reasoning: Key cedarwood constituents (cedrol, β-cedrene, thujopsene) inhibit major human CYP enzymes (notably CYP2B6 and CYP3A4) in vitro, which can raise blood levels of co-administered drugs and increase adverse effects or toxicity.</li> <li>Scientific_Study_Title: Inhibitory effects of cedrol, β-cedrene, and thujopsene on cytochrome P450 enzyme activities in human liver microsomes</li> <li>Scientific_Study_Authors: Hyeon-Uk Jeong, Soon-Sang Kwon, Tae Yeon Kong, Ju Hyun Kim, Hye Suk Lee</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25343299/</li> <li>Scientific_Study_Excerpt: <p>In human liver microsome assays, cedrol, β-cedrene and thujopsene (components of cedar oils) were potent competitive inhibitors of CYP2B6 and showed marked inhibition of CYP3A4 (cedrol Ki ≈ 3.4 μM). Thujopsene acted as a mechanism-based inhibitor of CYP2C8, CYP2C9 and CYP2C19. The authors conclude these sesquiterpenes warrant in vivo evaluation for potential pharmacokinetic drug interactions because they can substantially suppress key drug-metabolizing enzymes in vitro.</p> </li> </ul> <h3> Relative Contraindications of Devdaru </h3> <h4>Asthma or reactive airways disease [Caution with inhalation or strong vapor exposure]</h4> <ul> <li>😮‍💨</li> <li>Recommendation: People with asthma or COPD should avoid diffusing or inhaling concentrated essential oils (including cedarwood/Devdaru); discuss low-exposure trials with your clinician only if absolutely necessary.</li> <li>Reasoning: Essential oils can be respiratory irritants and may trigger bronchospasm or cough in susceptible individuals; guidelines and reviews recommend caution because odorants and volatile organic compounds can provoke symptoms.</li> <li>Scientific_Study_Title: Essential oils and its bioactive compounds modulating cytokines: A systematic review on anti-asthmatic and immunomodulatory properties</li> <li>Scientific_Study_Authors: (systematic review authors as listed in PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31036393/</li> <li>Scientific_Study_Excerpt: <p>Systematic review evidence shows essential oils and their constituents can modulate cytokines and airway inflammatory responses in preclinical models, but human data are limited; importantly, clinical guidance warns that inhaled oils may act as airway irritants and can trigger symptoms in patients with asthma, so routine use is not recommended without medical oversight.</p> </li> </ul> <h4>Severe liver disease or on multiple hepatically-metabolized drugs [Use with caution]</h4> <ul> <li>🧠</li> <li>Recommendation: If you have significant liver impairment or take several medicines cleared by the liver, avoid concentrated Devdaru products unless a physician advises careful monitoring; consider alternative therapies.</li> <li>Reasoning: Devdaru oil constituents distribute widely and several (cedrol, cedrene) inhibit major hepatic CYP enzymes in vitro - this may alter drug clearance and burden compromised liver function.</li> <li>Scientific_Study_Title: In vivo absorption and disposition of α-cedrene, a sesquiterpene constituent of cedarwood oil, in female and male rats</li> <li>Scientific_Study_Authors: (authors listed in PubMed entry)</li> <li>Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25857232/</li> <li>Scientific_Study_Excerpt: <p>Pharmacokinetic work in rats shows α-cedrene is orally absorbed, widely distributed (notably into lipid-rich tissues) and metabolized, demonstrating that cedarwood constituents reach systemic circulation and tissues. Combined with in vitro CYP inhibition data, these findings support caution in patients with impaired hepatic clearance or those taking multiple hepatically-metabolized drugs.</p> </li> </ul>